SB 1340
Modifies provisions relating to payments for prescription drugs, including 340B drugs
Sponsor:
LR Number:
5573S.01I
Committee:
Last Action:
12/1/2025 - Prefiled
Journal Page:
Title:
Effective Date:
August 28, 2026

Current Bill Summary

SB 1340 - Under this act, a health carrier, a pharmacy benefits manager, or an agent or affiliate of such, shall not discriminate against a covered entity, as defined in the act, including by reimbursing the covered entity for a quantity of a 340B drug in an amount less than it would pay similarly situated non-covered entities for such drugs, imposing different terms and conditions as compared to similarly situated entities, refusing to cover 340B drugs or discriminating in reimbursement for 340B drugs, and other situations described under this act. The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier, pharmacy benefits manager, or agent or affiliate of such, that violates this provision, not to exceed $5,000 per violation per day.

This act is identical to a provision in SCS/HCS/HB 943 (2025) and HB 784 (2025).

SARAH HASKINS

Amendments

No Amendments Found.